Back to search

Article

THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCE

2020-12-04

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Ivermectin is a commonly used antihelminthic agent with over 35 years of established safety data in humans. Recent data demonstrates antiviral activity in vitro against SARS-CoV-2, in addition to a range of viruses. In vitro and animal models also provide evidence of immunomodulatory action. These additional modes of action are supported by in silico modelling, which propose...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
53aef4ca-50c3-5c46-97f0-080811f7af28
DOI
10.1101/2020.11.30.20236570
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCEDOI 10.1101/2020.11.30.20236570
THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCESemantic proximity
Research Into Potential Therapies Against COVID-19, With Focus On IvermectinSemantic proximity
Research Into Potential Therapies Against COVID-19, With Focus On IvermectinSemantic proximity
Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replicationSemantic proximity
Minimal impact of ivermectin on immune response and transcriptional profiles in naïve adults with mild COVID-19Semantic proximity
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trialSemantic proximity
Pharmacometric assessment of the <i>in vivo</i> antiviral activity of ivermectin in early symptomatic COVID-19Semantic proximity
A comparison of Ivermectin and Non Ivermectin based regimen for covid 19 in Abuja: effects on virus clearance, Days-to-Discharge and Mortality.Semantic proximity
Exploring the Binding Efficacy of Ivermectin Against the Key Proteins of SARS-CoV-2 Pathogenesis: an in silico ApproachSemantic proximity
A Randomized Controlled Trial of Ivermectin Monotherapy Versus Hydroxychloroquine, Ivermectin, and Azithromycin Combination Therapy in Covid-19 Patients in NigeriaSemantic proximity
Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysisSemantic proximity
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological actionSemantic proximity
Select a neighboring publication to make it the new centre.